Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI was delisted on the 18th of March, 2025.
11 hedge funds and large institutions have $5.51M invested in Avenue Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
57% more funds holding
Funds holding: 7 → 11 (+4)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
48% more capital invested
Capital invested by funds: $3.72M → $5.51M (+$1.79M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.72M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$523K |
| 3 |
SIM
Spark Investment Management
New York
|
+$172K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$166K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$63.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$38.3K |
| 2 |
BlackRock
New York
|
-$6.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OM
1
Opaleye Management
Boston,
Massachusetts
| $3.8M | +$1.72M | +270 | +61% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $471K | +$166K | +26 | +42% |
|
|
EI
3
EAM Investors
Solana Beach,
California
| $437K | +$523K | +82 | New |
|
|
BRWA
4
B. Riley Wealth Advisors
Boca Raton,
Florida
| $282K | -$38.3K | -6 | -10% |
|
|
SIM
5
Spark Investment Management
New York
| $144K | +$172K | +27 | New |
|
|
FWM
6
Frontier Wealth Management
Kansas City,
Missouri
| $95K | – | – | – |
|
|
7
BlackRock
New York
| $80K | -$6.38K | -1 | -6% |
|
8
Northern Trust
Chicago,
Illinois
| $69K | – | – | – |
|
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $51K | +$63.8K | +10 | New |
|
10
Renaissance Technologies
New York
| $51K | +$63.8K | +10 | New |
|
11
UBS Group
Zurich,
Switzerland
| $23K | +$6.38K | +1 | +33% |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
ATXI Hedge Fund Activity: Q1 2019 in Review
11 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Avenue Therapeutics, Inc. Common Stock (ATXI) for Q1 2019, worth a combined $5.51M — up 48% from $3.72M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATXI positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Opaleye Management, adding an estimated $1.72M. The largest seller was B. Riley Wealth Advisors, cutting an estimated $38.3K.
- 11 institutional investors held Avenue Therapeutics, Inc. Common Stock (ATXI) as of Q1 2019, up from 7 in Q4 2018.
- Funds reported $5.51M of Avenue Therapeutics, Inc. Common Stock stock for Q1 2019, up 48% quarter-over-quarter.
- 4 funds opened new Avenue Therapeutics, Inc. Common Stock positions in Q1 2019 and 0 closed out, a net change of +4 holders.
- The largest Avenue Therapeutics, Inc. Common Stock buyer in Q1 2019 was Opaleye Management, an estimated $1.72M added.
- The largest Avenue Therapeutics, Inc. Common Stock seller in Q1 2019 was B. Riley Wealth Advisors, an estimated $38.3K sold.
Based on aggregated 13F filings for Q1 2019.